People with human immunodeficiency virus (HIV) (PWH) with 4-drug class resistance (4DR) had a higher risk of death than non-4DR PWH, primarily due to lower CD4 cell counts. The priority for this vulnerable population is achieving virological control to enable immune recovery.

All-Cause Mortality in People With Four-Class Drug-Resistant Human Immunodeficiency Virus: A Matched Cohort Analysis With Data From the PRESTIGIO Registry / Giacomelli, Andrea; Capra, Nicolò; Lolatto, Riccardo; Gagliardini, Roberta; Clemente, Tommaso; Calza, Leonardo; Torti, Carlo; Lagi, Filippo; Fornabaio, Chiara; Marchetti, Giulia; Orofino, Giancarlo; Spagnuolo, Vincenzo; Castagna, Antonella; Bagaglio, Sabrina; Muccini, Camilla; Galli, Andrea; Borjesson, Rebecka Papaioannu. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - 81:5(2025), pp. 370-374. [10.1093/cid/ciaf421]

All-Cause Mortality in People With Four-Class Drug-Resistant Human Immunodeficiency Virus: A Matched Cohort Analysis With Data From the PRESTIGIO Registry

Clemente, Tommaso;Spagnuolo, Vincenzo
Ultimo
;
Castagna, Antonella
Membro del Collaboration Group
;
Bagaglio, Sabrina
Membro del Collaboration Group
;
Muccini, Camilla
Membro del Collaboration Group
;
Galli, Andrea
Membro del Collaboration Group
;
Borjesson, Rebecka Papaioannu
Membro del Collaboration Group
2025-01-01

Abstract

People with human immunodeficiency virus (HIV) (PWH) with 4-drug class resistance (4DR) had a higher risk of death than non-4DR PWH, primarily due to lower CD4 cell counts. The priority for this vulnerable population is achieving virological control to enable immune recovery.
2025
Inglese
OXFORD UNIV PRESS INC
81
5
370
374
5
Pubblicato
https://academic.oup.com/cid/article/81/5/e370/8221079?login=false
Esperti anonimi
Internazionale
Goal 3: Good health and well-being
death
immune suppression
multidrug resistance
outcome
heavily treatment experienced
No
All-Cause Mortality in People With Four-Class Drug-Resistant Human Immunodeficiency Virus: A Matched Cohort Analysis With Data From the PRESTIGIO Registry / Giacomelli, Andrea; Capra, Nicolò; Lolatto, Riccardo; Gagliardini, Roberta; Clemente, Tommaso; Calza, Leonardo; Torti, Carlo; Lagi, Filippo; Fornabaio, Chiara; Marchetti, Giulia; Orofino, Giancarlo; Spagnuolo, Vincenzo; Castagna, Antonella; Bagaglio, Sabrina; Muccini, Camilla; Galli, Andrea; Borjesson, Rebecka Papaioannu. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - 81:5(2025), pp. 370-374. [10.1093/cid/ciaf421]
open
17
info:eu-repo/semantics/article
262
Giacomelli, Andrea; Capra, Nicolò; Lolatto, Riccardo; Gagliardini, Roberta; Clemente, Tommaso; Calza, Leonardo; Torti, Carlo; Lagi, Filippo; Fornabaio...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
File in questo prodotto:
File Dimensione Formato  
ciaf421.pdf

accesso aperto

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Creative commons
Dimensione 1.39 MB
Formato Adobe PDF
1.39 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/191460
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact